Schedule 13D ownership disclosure
Arcutis Biotherapeutics Inc
Security class unavailable · CUSIP: 03969K108
Event date: 2022-04-06
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 7.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000947871-22-000449
- Form type
- SC 13D
- Filer
- Arcutis Biotherapeutics, Inc.
- CIK
- CIK 1787306
- Filed
- Apr 08, 2022
- Reporting period
- Apr 06, 2022
- Description
- Schedule 13D beneficial ownership